LANTERN Phase III Supports Nasal Photodisinfection Before Surgery

Evidence Regulatory disclosure · Discovery September 10, 2026 · Importance 4/5 · Direction Positive Summary Ondine Biomedical reported that the 5,188-patient Phase III LANTERN trial met its prespecified primary endpoint: adding a single preoperative nasal photodisinfection procedure to standard care produced an estimated 40.5% reduction…